FDC Obtains FDA Approval for Ciprofloxacin Opthalmic Solution

FDC announced that the company has obtained an approval from US FDA for its Abbreviated New Drug Application Ciprofloxacin Ophthalmic Solution that is used for occular surface infections.
RTTNews